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Abstract. 2-methoxy-4-((4-methoxyphenilimino)-methyl)-phenol compound is a Schiff base 
compound synthesized from vanillin and p-anisidin. The purpose of this research is to determine 
the stability of the 2-methoxy-4-((4-methoxyphenilimino) methyl) phenol compound and to test 
the anticancer activity of 2-methoxy-4-((4-methoxyphenilimino) methyl) phenol in inhibiting 
T47D breast cancer cells. The stability of the 2-methoxy-4-((4-methoxy-phenylimino)-methyl)-
phenol compound was carried out by characterization using chemical tests, identification using 
FTIR and GC-MS. While the anticancer activity test of compound 2-methoxy-4-((4-
methoxifenilimino) methyl) phenol using the MTT method. The results of re-characterization 
using chemical tests, identification of FTIR and KG-SM showed the compound was still stable. 
The IC50 value of compound 2-methoxy-4-((4-methoxyphenilimino) methyl) phenol was 
353,038 μg / mL which showed weak activity in inhibiting T47D breast cancer cells. 
1.  Introduction 
Cancer is the second disease that causes death worldwide after cardiovascular disease and more than 
70% of cancers occur in developing countries. Deaths due to disease are increasing in 2030 [1]. 
According to WHO, cancer patients every year increase by around 6.25 million people [2]. 
Breast cancer is the most common cancer among women in the world with an incidence that increases 
1-2% every year [3]. In Indonesia, this cancer is ranked second after cervical cancer with 17.77% 
incidence cases [4]. So, to reduce the percentage of patients with breast cancer, it is necessary to develop 
a chemopreventive agent or a compound that can prevent and inhibit the development of cancer. 
The breast cancer cell used in this study was T47D. T47D is a continuous cell line isolated from 
breast ductal tumor tissue in a 54-year-old woman. Continuous cell line is often used in cancer research 
in vitro because this cancer cell is easy handling, has unlimited replication ability, high homogeneity, 
and this cancer cell is easily replaced with frozen stock in case of contamination. The cell line is cells 
subcultured from primary cultures, or cells originating from organs or tissues that are cultured under 
appropriate hormonal conditions [5]. 
Schiff base compounds are primary amine condensation products with carbonyl compounds. The 
main characteristic of this compound structure is that it has the general formula RHC = N-R1, where R 
and R1 are alkyls, aryl, cycloalkyl or heterocyclic [6]. Imines or Schiff base is also a group of compounds 
that have important biological roles as antioxidants [7], anti-inflammatory and analgesic agents [8], 
antifungal [6], antimalarials [9], antibacterial [10]. In addition, Schiff base compounds can also function 
as anticancer compounds such as studies conducted by Mokhles et al. [11] and Gupta et al. [12]. 
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Research conducted by Mokhles et al. states that the Schiff base compounds resulting from the 
reaction between salicylaldehyde and 2-amino-4-phenyl-5-methyltiazole have anticancer activity 
against HepG2, MCF-7, and HCT116 cells with IC50 values consecutively 9,22 μgmL
-1, 10,00 μgmL-1, 
dan 9,50μgmL-1. Other research was also carried out by Gupta et al. (2015) which stated that schiff base 
product of 2,4-dihydroxybenzaldehyde with various primary amines of butylamine, aniline, and 4-(1H-
benzo[d]imidazole-2-yl)aniline had anticancer activity against PC3 cells. The test was carried out by the 
MTT method which yielded IC50 values consecutively 7.43 μM, 7.15 μM, and 4.83 μM. Meanwhile, 
based on research conducted by Zhao et al.[13], Schiff base compounds derived from 
dehydroabietilamine have anticancer activity against Hela cells, HepG2, MCF-7, A549, HUVEC. As in 
the imidazole-2-formaldehyde-dehydroabietilamine compound IC50 values consecutively were 
3,22±0,02 μM, 0,24±0,01 μM, 4,28±0,70 μM, 3,17±0,05 μMdan 7,67±0,43 μM. 
Based on these studies, an anticancer activity test was carried out on 2-methoxy-4- ((4-
methoxyphenylimino) methyl) -phenol compounds synthesized by Adawiyah (2017) [14] on T47D 
breast cancer cells. Before conducting anticancer tests, characterization was first performed using FTIR 
and GC-MS as well as chemical testing with NaOH solution to ensure the compound was not damaged 
due to storage. 
2.  Methods 
2.1.   Materials 
2-methoxy-4-((4-methoxyphenylimino)methyl)phenol Compound that has been stored ± 1 year (Sample 
A), vanillin, p-anisidine, 2M NaOH, aquades, chloroform, PBS (Phosphate Buffered Saline), trypsin-
EDTA, RPMI (Roswell Park Memorial Institute) culture media, DMSO (Dimethyl Sulfoxide), MTT 5 
mg / mL (50 mg MTT and 10 mL PBS), SDS (Sodium Dodecyl Sulfate) 10%, HCl 0.1 M.  
2.2.   Methods 
2.2.1  Characterization 2-methoxy-4-((4-methoxyphenylimino)-methyl)-phenol CompoundUsing 
Chemistry Test. A chemical test sample of product A was tested in the water solvent. 0.01 gram of 
sample A product is put into a test tube, then add 5 mL of aquades. The mixture is shaken with a stirring 
distance of 10 cm. if the product A sample is not completely dissolved, then add 2 M NaOH drops per 
drop (±20 μL) and observe the changes that occur. 
2.2.2  Characterization 2-methoxy-4-((4-methoxyphenylimino)-methyl)-phenol CompoundUsing FTIR. 
Identification of functional groups of phenol compounds from 2-methoxy-4-((4-methoxyphenilimino)-
methyl)-phenol compounds in sample A using FTIR VARIAN type FT-1000 spectrophotometer. Then 
A sample mixed with KBr and crushed in an agate mortar. Then the mixture is pressed and formed into 
a pellet, then the pellet is placed in a cell holder in the FTIR instrument and the FTIR spectrum is made 
in the range of 4000-400 cm-1 wavenumbers. 
2.2.3  Characterization 2-methoxy-4-((4-methoxyphenylimino)-methyl)-phenol CompoundUsing GC-
MS. A total of 1 μL of sample A dissolved in chloroform at a concentration of 70,000 ppm was injected 
using a syringe into the KG-SM VARIAN CP-3800 SATURN 2200 injector. 
2.2.4  Test of Anticancer Activity. Samples A, Vanillin, and p-anisidin were prepared in a series of 
concentrations of 1000, 500, 250, 125, 62.5, 31.25, 15.63 ppm. Each concentration series is made three 
times. T47D breast cancer cell suspension (50x104 cells/mL) was put into a plate containing 96 wells 
and incubated for 24 hours. After 24 hours the media was removed and washed with PBS, a series of 
concentrations of sample A, vanillin, p-anisidin and doxorubicin were added to the well and then 
incubated for 24 hours. At the end of the incubation, the solution in the dish is discarded and washed 
with PBS then MTT reagent is added and incubated 37ºC/5% CO2 for 2-4 hours. 
After formazan salt is formed, 10% SDS stopper and 0.1 N HCl are added. Then the plates were 
incubated in a dark place at room temperature overnight. After that, the treatment results are read out 
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the absorbance results using an Elisa reader with a wavelength of 595 nm. Living cells will react with 
MTT to form a purple color. Then calculate the percentage of living cells with the following equation. 
%living cell= 
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3.  Results and discussion 
3.1.  Characterization 2-methoxy-4-((4-methoxyphenylimino)methyl)phenol Compound Using 
Chemistry Test 
Chemical tests on sample A were carried out to determine the presence of phenolic groups in sample A. 
The test was based on the principle of the Bronsted-Lowry acid-base reaction, a reaction involving 
proton transfer. The compound 2-methoxy-4- ((4-methoxyphenilimino)-methyl)-phenol acts as an acid 
and NaOH acts as a base. The acid-base reaction will produce salts that are soluble in water. 
 
Figure 1. Bronsted-Lowry acid-base reaction. 
Schiff base compound 2-methoxy-4-((4-methoxyphenilimino)methyl)phenol is a phenolic 
compound that has acidic properties and can release H+ ions from the hydroxyl group. The OH- ion in 
NaOH attacks the H+ ion in the phenolic group of Schiff base compounds and forms H2O shown in 
figure 1. While Na+ ions will replace the loose H+ ions in Schiff base compounds to form sodium salt 
that can dissolve in water. 
3.2.  Characterization 2-methoxy-4-((4-methoxyphenylimino)methyl)phenol Compound Using FTIR 
Characterization of sample A by using an FTIR spectrophotometer was performed to determine the 
functional groups contained in the sample. Spectra analysis has been obtained compared to initial 
characterization before storage. It aims to find out that sample A is still stable and not damaged due to 
storage shown in figure 2. 
 
Figure 2. Results of FTIR spectra of 2-methoxy-4-((4-methoxyphenilimino)methyl)phenol after being 
stored for ± 1 year (A) and 2-methoxy-4-((4-methoxyphenilimino)methyl)phenol synthesized 
beginning (B). 
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Table 1. Results of FTIR identification of 2-methoxy-4-((4-methoxyphenilimino)-methyl) 
phenol compound. 
Functional Groups Wave Number (cm-1) 
Sample A Sample B 
-OH stretch 3449 3451 
Csp2-H stretch aromatic 3009 3009 
Csp3-H stretch alifatic 2954 2950 
Overtone aromatic 2050-1879 2050-1880 
C=C aromatic 1623 dan 1508 1623 dan 1506 
-C=N- stretch 1590 1590 
Ph-O-C asymmetric 1247 1246 
C-O stretch phenol 1212 1212 
Ph-O-C symmetric 1028 1029 
-CH2bend aromatic 829 831 
Sample A : 2-methoxy-4-((4-methoxyphenilimino)-methyl)-phenol compound after being stored for ± 1 year. 
Sample B : 2-methoxy-4-((4-methoxyphenilimino)-methyl)-phenol compound in initial synthesis (2017) 
 
The re-characterization results on the FTIR spectrophotometer showed that in table 1 and figure 2, 
the wavenumber values obtained were slightly different from the initial characterization. The difference 
in the IR spectra before storage with the re-characterization is seen in the typical widening intensity of 
the -OH group in the area of 3400-3450 cm-1 shown in table 1. However, the difference obtained from 
each functional group is not too significant and there are only a few differences in wavenumbers with 
the initial characterization before storage. This shows that 2-methoxy-4-((4-methoxyphenilimino)-
methyl)-phenol compound is structurally unchanged and the compound is not damaged during storage. 
 
3.3 Characterization 2-methoxy-4-((4-methoxyphenilimino)methyl)phenol Compound Using GC-MS 
The characterization results using GC-MS have produced 3 peaks in the chromatogram results as shown 
in Figure 3 in sample A. The first peaks appear at a retention time of 9.319 minutes and 0.86% level. 
While the second peak appeared at a retention time 14.990 minutes and 4.87% level. The third peak 
appeared at a retention time of 26.791 minutes and 94,267% levels. This shows that the third peak has 
the most dominant level than the results of the other peaks. 
Based on the results of the sample A chromatogram that has been obtained, these results have 
differences with the results of the sample chromatogram B. The difference in the chromatogram lies in 
the number of chromatograms obtained, which are 3 peaks in the re-characterization, and 2 peaks in the 
initial characterization with different retention times. This can be caused by differences in the tools used, 
in sample A using KG-SM VARIAN CP-3800 SATURN 2200. While sample B using KG-SM QP-
2010S / Shimadzu. In addition, in sample A, the peaks of the chloroform solvent were excluded or 
removed so that the small peaks that appeared could be read. Whereas in sample B the chloroform 
solvent was included in the final result so that the small peaks produced were not readable at retention 
time and the area. 
Sample B levels reached 97.66%, while the results of the characterization of sample B decreased to 
94.267%. The decrease in product yields accompanied by the appearance of another peak which is a 
reactant as shown in Figure 3 in sample A can be caused due to a backlash event on the results of the 
synthesis product. The back reaction can occur due to the hydrolysis of the 2-methoxy-4- ((4-
methoxyphenylimino) methyl) -phenol compound which can be caused by storage with a long period of 









































M Co un ts Ba sa  S chif f 2 (L a ila  S .) .S M S T IC


































Figure 3. Spectra Result of chromatogram from sample A of Schiff base compound after ± 1 year of 










Figure 4. Peak 1 Mass Spectra of Sample A. 
The results of peak 1 mass spectra analysis in sample A are shown in Figure 4. The peak mass spectra 
1 in sample A has a molecular ion with m/z 123 whose value is equal to the molecular weight of p-
anisidin, so peak 1 is thought to be a p-anisidin compound. p-anisidin (C7H9NO) is a reactant of the 
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Figure 5. Peak 2 Mass Spectra of Sample A. 
The results of peak 2 mass spectra analysis in sample A are shown in Figure 5. Peak mass spectra 2 
have m/z 152 molecular ions whose value is equal to the molecular weight of vanillin, so peak 2 is 












Figure 6. Peak 3 Mass Spectra of Sample A. 
 
The peak mass spectra 3 in Figure 6. shows that the value of m/z 257 with an abundance of 100% is 
molecular ion and base peak. The molecular ion value of m/z 257 corresponds to the molecular weight 
of the 2-methoxy-4-((4-methoxyphenilimino)methyl)phenol compound. 
3.4.  Anticancer Activity Test 
Anticancer activity testing is carried out to determine the ability of 2-methoxy-4-((4-
methoxyphenilimino)methyl)phenol compound to inhibit the growth of breast cancer cells. Testing was 
carried out in vitro against T47D breast cancer cells with the MTT method. The sample concentration 
used 1000; 500; 250; 125; 62.5; 31.25; 15.63 ppm. 
Table 2. IC50 values for Anticancer Activity Test. 






p-Anisidin 176, 642 
Doxorubicin 0,627 
Based on Table 2. shows that sample A has weak activity in inhibiting T47D breast cancer cells with 
IC50 353,038 μg/mL, and vanillin has lower activity compared to sample A with IC50 845,134 μg/mL, 
and p-anisidin is quite active in inhibits T47D breast cancer cells with IC50 176,642 μg/mL. The positive 
control results of Doxorubicin showed that the compound was very active in inhibiting T47D breast 
cancer cells with IC50 0,627 μg/mL. This is based on the US National Cancer Institute when IC50 values 
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moderately active. When IC50 values of 201-500 μg/mL indicate weak oxidation, and when IC50≥ 500 
μg/mL show non-toxic results. 
Schiff base compounds are generally biosynthetic alkaloid compounds [15], where alkaloids can 
inhibit the activity of T47D breast cancer cells in the G1 phase by increasing p53 which is a protein that 
inhibits cancer cells [16]. The effect of anticancer activity from sample A can be influenced by the 
phenolic group who are in the position of para who can provide greater activity. As research conducted 
by Mohamed et al. [17] shows that the compound 4-[(3-Ethoxy-4-hydroxy-benzylidene)-amino]-
benzenesulfonamide which is also a Schiff base compound which has a phenolic group in position para 
can be active in inhibiting breast cancer cells with an IC50 value of 96 μM. Whereas the compound 4-
{[(2-Hydroxyphenyl)methylidene]amino}benzenesulfonamidewhich has a phenolic group in the ortho 
position has an IC50 value of 101 in breast cancer cells. 
The activity of p-Anisidin compound in inhibiting T47D breast cancer cells cannot be used in the 
development of further chemopreventive agents. This is because the p-Anisidin compound can actually 
cause cancer if it enters the body (Merck Chemicals). In addition, based on research conducted by 
Yoshida et al. [18] that the p-anisidin compound is a nephrotoxic compound against 344 male Fischer 
rats, which means that the p-anisidin compound can cause kidney damage if it enters the body. 
4.  Conclusion 
Based on the re-characterization of 2-methoxy-4-((4-methoxyphenilimino)methyl)phenol compound 
using chemical test, identification with FTIR and GC-MS showed that the Schiff base compound was 
stable, and was not damaged by storage. The results of the anticancer activity of 2-methoxy-4-((4-
methoxyphenilimino)methyl)phenol compounds have weak activity in inhibiting T47D breast cancer 
cells with IC50 values of 353,038 μg/mL. 
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